Skip to main content
. 2020 Jun 23;4(9):bvaa076. doi: 10.1210/jendso/bvaa076

Table 1.

Participant characteristics at enrollmenta

Overall T1D T2D Pump Injections
(N = 34) (N = 27) (N = 7) (N = 7) (N = 27)
Age,y, mean ± SD 46 ± 18 42 ± 18 60 ± 7 41 ± 19 47 ± 17
Sex—female, n (%) 18 (53%) 14 (52%) 4 (57%) 5 (71%) 13 (48%)
Race/Ethnicity n (%)
White 29 (85%) 25 (93%) 4 (57%) 6 (86%) 23 (85%)
Black/African American 3 (9%) 0 (0%) 3 (43%) 0 (0%) 3 (11%)
Unknown/not reported 2 (6%) 2 (7%) 0 (0%) 1 (14%) 1 (4%)
BMI median (quartiles) 28.9 (25.2, 36.1) 27.0 (24.4, 33.5) 37.8 (32.2, 44.0) 27.8 (21.2, 35.0) 29.3 (25.2, 37.8)
Education level, n (%)
< Bachelor degree 17 (50%) 12 (44%) 5 (71%) 5 (71%) 12 (44%)
Bachelor degree 11 (32%) 11 (41%) 0 (0%) 2 (29%) 9 (33%)
> Bachelor degree 6 (18%) 4 (15%) 2 (29%) 0 (0%) 6 (22%)
Annual household income, $, n (%)
< 50 000 14 (41%) 11 (41%) 3 (43%) 5 (71%) 9 (33%)
50 000-< 100 000 11 (32%) 9 (33%) 2 (29%) 1 (14%) 10 (37%)
≥ 100 000 9 (26%) 7 (26%) 2 (29%) 1 (14%) 8 (30%)
Diabetes duration, y, median (quartiles)b 22 (11, 30) 23 (11, 30) 18 (5, 24) 26 (14, 47) 20 (10, 29)
HbA1c mean ± SDc 8.3 ± 1.6 8.4 ± 1.7 8.1 ± 1.3 8.1 ± 2.1 8.4 ± 1.5
Estimated % time in range (70-180 mg/dL)d 48% ± 18% 48% ± 19% 51% ± 14% 51% ± 24% 48% ± 17%
Estimated mean glucose, mg/dLd,e 196 ± 46 197 ± 49 189 ± 36 190 ± 60 197 ± 43

Abbreviations: HbA1c, hemoglobin A1c; T1D, type 1 diabetes; T2D, type 2 diabetes.

aExcludes one individual who withdrew from the study shortly after enrollment and did not provide any data.

bMissing for 2 participants with T2D.

cSI conversions: To convert HbA1c to SI units of mmol/mol, multiply HbA1c percentage value × 10.93 and subtract 23.5 from the product.

dEstimated from Beck et al [26].

eSI conversion: To convert glucose to mmol/L, multiply values × 0.0555.